The Clorox Company (BMV:CLX)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 7, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	278,854	279,082	309,604	337,135	349,780	445,643
Market Cap Growth	-9.86%	-9.86%	-8.17%	-3.62%	-21.51%	-30.08%
Enterprise Value	333,196	333,412	363,768	387,753	412,572	502,703
Last Close Price	2368.08	2300.00	2523.48	2439.12	2561.17	3059.94
PE Ratio	18.26	18.27	60.53	131.95	37.56	31.52
PS Ratio	2.08	2.08	2.39	2.66	2.44	3.05
PB Ratio	30.68	30.70	34.45	50.67	23.80	37.80
P/FCF Ratio	-	-	35.09	21.14	32.43	23.68
P/OCF Ratio	-	-	24.39	16.98	22.08	17.54
EV/Sales Ratio	2.51	2.49	2.81	3.06	2.88	3.44
EV/EBITDA Ratio	11.43	11.79	17.38	21.79	22.06	17.57
EV/EBIT Ratio	15.01	13.77	21.62	27.85	28.75	20.49
EV/FCF Ratio	23.22	-	41.23	24.32	38.26	26.71
Debt / Equity Ratio	5.98	5.98	5.97	7.61	4.28	5.38
Debt / EBITDA Ratio	1.70	1.70	2.19	2.43	2.85	2.05
Debt / FCF Ratio	-	-	6.08	3.18	5.84	3.37
Asset Turnover	1.26	1.26	1.21	1.22	1.14	1.17
Inventory Turnover	6.71	6.71	6.04	6.18	6.05	6.85
Quick Ratio	0.52	0.52	0.57	0.55	0.48	0.45
Current Ratio	0.84	0.84	1.03	0.95	0.97	0.89
Return on Equity (ROE)	169.20%	169.20%	66.36%	28.83%	71.31%	95.87%
Return on Assets (ROA)	14.19%	14.19%	9.84%	8.39%	7.12%	12.27%
Return on Capital (ROIC)	23.63%	23.63%	17.00%	14.11%	11.67%	19.69%
Return on Capital Employed (ROCE)	35.30%	35.30%	22.00%	20.20%	16.30%	28.80%
Earnings Yield	5.48%	5.47%	1.65%	0.76%	2.66%	3.17%
FCF Yield	5.15%	-	2.85%	4.73%	3.08%	4.22%
Dividend Yield	4.08%	4.02%	3.49%	3.33%	3.67%	2.92%
Payout Ratio	78.49%	-	212.50%	391.27%	123.59%	78.59%
Buyback Yield / Dilution	0.41%	0.41%	-0.50%	-0.22%	2.67%	0.29%
Total Shareholder Return	4.49%	4.43%	2.99%	3.11%	6.33%	3.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.